Articles From: BioAmber Inc. announces pricing of $33.6 million registered offering to Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital


BioAmber Inc. announces pricing of $33.6 million registered offering Canada NewsWire MINNEAPOLIS, MN , July 16, 2014 /CNW/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that it has priced an underwritten registered offering of 2,800,000 shares of its common stock at a price of $12.00 per share, and granted the underwriters in the offering a 30-day option to purchase up to an additional 420,000 shares of its common stock.
Sign-up for BioAmber Inc. announces pricing of $33.6 million registered offering investment picks
MINNEAPOLIS, MN , July 16, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that it has priced an underwritten registered offering of 2,800,000 shares of its common stock at a price of $12.00 per share, and granted the underwriters in the offering a 30-day option to purchase up to an additional 420,000 shares of its common stock.
Sign-up for BioAmber Inc. announces pricing of $33.6 million registered offering investment picks
BioAmber Inc. announces public offering of common stock Canada NewsWire MINNEAPOLIS, MN , July 15, 2014 /CNW Telbec/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that it has commenced a public offering of 2,800,000 shares of its common stock.
Sign-up for BioAmber Inc. announces public offering of common stock investment picks
MINNEAPOLIS, MN , July 15, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that it has commenced a public offering of 2,800,000 shares of its common stock.
Sign-up for BioAmber Inc. announces public offering of common stock investment picks
BioAmber Reports Second Quarter 2014 Financial Results Canada NewsWire MINNEAPOLIS, MN , Aug.
Sign-up for BioAmber Reports Second Quarter 2014 Financial Results investment picks
MINNEAPOLIS, MN , Aug.
Sign-up for BioAmber Reports Second Quarter 2014 Financial Results investment picks
BioAmber Secures $7 Million Grant From SDTC Canada NewsWire MINNEAPOLIS, MN , July 2, 2014 BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that its Canadian subsidiary BioAmber Sarnia Inc., a Joint Venture with Mitsui & Co., has secured a CDN $7 million grant from Sustainable Development Technology Canada (SDTC). The funds will be used to support the ongoing construction of the CDN$135 million ( US$125 million ) bio-succinic acid plant that is under construction in Sarnia Ontario.
Sign-up for BioAmber Secures $7 Million Grant From SDTC investment picks
MINNEAPOLIS, MN , July 2, 2014 BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that its Canadian subsidiary BioAmber Sarnia Inc., a Joint Venture with Mitsui & Co., has secured a CDN $7 million grant from Sustainable Development Technology Canada (SDTC). The funds will be used to support the ongoing construction of the CDN$135 million ( US$125 million ) bio-succinic acid plant that is under construction in Sarnia Ontario.
Sign-up for BioAmber Secures $7 Million Grant From SDTC investment picks
BioAmber Secures CAD$20 Million Loan for Sarnia Plant Canada NewsWire MINNEAPOLIS, MN , June 23, 2014 /CNW Telbec/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that its Canadian subsidiary BioAmber Sarnia Inc., a joint venture with Mitsui & Co., has secured a CAD$20 million commercial loan from a financial consortium led by Export Development Canada and including Farm Credit Canada and Comerica Bank.
Sign-up for BioAmber Secures CAD$20 Million Loan for Sarnia Plant investment picks
MINNEAPOLIS, MN , June 23, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that its Canadian subsidiary BioAmber Sarnia Inc., a joint venture with Mitsui & Co., has secured a CAD$20 million commercial loan from a financial consortium led by Export Development Canada and including Farm Credit Canada and Comerica Bank.
Sign-up for BioAmber Secures CAD$20 Million Loan for Sarnia Plant investment picks
Vinmar commitment is for 210,000 tons of succinic acid per year when three plants operational Contract guarantees sale of 10,000 tons per year for 15 years from Sarnia plant in construction 50% of Sarnia capacity is under take-or-pay, with total contracted demand exceeding capacity Previously announced 100,000 ton per year BDO plant will be expanded to also produce 70,000 tons per year of succinic acid, with Vinmar off-taking 100% of the BDO produced and 70% of the bio-succinic acid produced for 15 years Vinmar also commits to off-take 75% of the production from a new, third bio-succinic acid plant with 200,000 MT per year capacity that BioAmber currently plans to startup in 2020 Vinmar commits to a 10% or greater equity investment in each of the next two plants MINNEAPOLIS, MN , July 7, 2014 /CNW Telbec/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced it has signed a
Sign-up for BioAmber Signs Take-or-Pay Contract For Three Bio-Succinic Acid Plants investment picks
TEL AVIV, Israel, Aug.
Sign-up for BioBlast Pharma Reports Second Quarter Financial Results investment picks
TEL AVIV, Israel, Sept.
Sign-up for BioBlast to Ring the NASDAQ Stock Market Opening Bell investment picks
SAN DIEGO, Aug.
Sign-up for Biocept Provides Second Quarter Operational Update investment picks
SAN DIEGO, Sept.
Sign-up for Biocept Strengthens Its Circulating Tumor Cell IP Position in Europe investment picks
SAN DIEGO, Sept.
Sign-up for Biocept to Present at Upcoming Investor Conferences investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst Participates in World Health Organization Consultation on Potential Ebola Therapies investment picks
RESEARCH TRIANGLE PARK, N.C., Aug.
Sign-up for BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases investment picks
RESEARCH TRIANGLE PARK, N.C., Aug.
Sign-up for BioCryst Receives Additional NIAID Funding to Conduct a Non-Human Primate Study of BCX4430 in Ebola Virus Disease investment picks
RESEARCH TRIANGLE PARK, N.C., Aug.
Sign-up for BioCryst Reports Second Quarter 2014 Financial Results investment picks
RESEARCH TRIANGLE PARK, N.C., May 24, 2014 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. , (Nasdaq:BCRX) today announced that management plans to report results for the OPuS-1 ( O ral P rophylaxi S-1 ) proof of concept Phase 2a clinical trial of orally-administered BCX4161 in patients with hereditary angioedema (HAE) the morning of Tuesday, May 27, 2014.
Sign-up for BioCryst to Announce Results From the BCX4161 OPuS-1 Phase 2 Trial for Hereditary Angioedema May 27 investment picks
RESEARCH TRIANGLE PARK, N.C., July 22, 2014 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that its second quarter 2014 financial results will be released on Tuesday, August 5, 2014.
Sign-up for BioCryst to Announce Second Quarter 2014 Financial Results August 5 investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst to Present at Rodman & Renshaw Conference investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020442-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/25/11G020442/Biodel_Life_Delivered_600dpi-1189716966656.jpg DANBURY, CT--(Marketwired - August 25, 2014) - Biodel Inc. (NASDAQ: BIOD) today announced that Gary G.
Sign-up for Biodel Appoints Gary G. Gemignani as Chief Financial Officer investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G019045-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/7/25/11G019045/Biodel-Life-Delivered_000-1401197537254.jpg DANBURY, CT--(Marketwired - July 28, 2014) - Biodel Inc. (NASDAQ: BIOD) today announced that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"), a Chicago-based institutional investor.
Sign-up for Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: BioAmber Inc. announces pricing of $33.6 million registered offering to Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices